Article History
First Online: 15 June 2023
Competing interests
: H.L. reports receiving grants from Shire Pharmaceuticals; receiving personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; and receiving sponsorship for a conference on attention-deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. H.L. is editor-in-chief of <i>JCPP Advances</i>.